ASCITES HEPATIC
Clinical trials for ASCITES HEPATIC explained in plain language.
Never miss a new study
Get alerted when new ASCITES HEPATIC trials appear
Sign up with your email to follow new studies for ASCITES HEPATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug help drain dangerous belly fluid?
Disease control OngoingThis study looks at whether SGLT2 inhibitors, a type of diabetes medication, can help control ascites (fluid buildup in the belly) in people with liver cirrhosis and type 2 diabetes. Researchers will compare 40 patients who add the drug to their usual treatment against those who …
Matched conditions: ASCITES HEPATIC
Sponsor: University of Palermo • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a lung drug save kidneys in liver patients?
Disease control OngoingThis study tests whether ambrisentan, a drug approved for lung blood pressure, can help patients with hepatorenal syndrome—a serious kidney problem that can occur in advanced liver cirrhosis. About 54 hospitalized adults will receive either ambrisentan or the standard drug terlip…
Matched conditions: ASCITES HEPATIC
Phase: PHASE2 • Sponsor: Noorik Biopharmaceuticals AG • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC